185 related articles for article (PubMed ID: 36034435)
1. Cdc42 upregulation under high glucose induces podocyte apoptosis and impairs β-cell insulin secretion.
Jiang S; Xu CM; Yao S; Zhang R; Li XZ; Zhang RZ; Xie TY; Xing YQ; Zhang Q; Zhou XJ; Liao L; Dong JJ
Front Endocrinol (Lausanne); 2022; 13():905703. PubMed ID: 36034435
[TBL] [Abstract][Full Text] [Related]
2. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy.
Ma R; Wang Y; Xu Y; Wang R; Wang X; Yu N; Li M; Zhou Y
J Diabetes Res; 2021; 2021():8832114. PubMed ID: 34095318
[TBL] [Abstract][Full Text] [Related]
4. Formyl peptide receptor 1 promotes podocyte injury through regulation of mitogen-activated protein kinase pathways.
Zhang J; Ding T; Tang D; Wang J; Huang P
Exp Biol Med (Maywood); 2022 Jan; 247(2):87-96. PubMed ID: 34565207
[TBL] [Abstract][Full Text] [Related]
5. Sp1-mediated upregulation of Prdx6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis.
Zhang Q; Hu Y; Hu JE; Ding Y; Shen Y; Xu H; Chen H; Wu N
Life Sci; 2021 Aug; 278():119529. PubMed ID: 33894270
[TBL] [Abstract][Full Text] [Related]
6. Lycopene attenuates high glucose-mediated apoptosis in MPC5 podocytes by promoting autophagy via the PI3K/AKT signaling pathway.
Wang Q; Li R; Xiao Z; Hou C
Exp Ther Med; 2020 Sep; 20(3):2870-2878. PubMed ID: 32765784
[TBL] [Abstract][Full Text] [Related]
7. [MiR-34a alleviates podocyte injury in mice with diabetic nephropathy by targeted downregulation of Notch signaling pathway].
Wang H; Liu H; Zhang Y; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1839-1845. PubMed ID: 36651252
[TBL] [Abstract][Full Text] [Related]
8. Metadherin facilitates podocyte apoptosis in diabetic nephropathy.
Liu WT; Peng FF; Li HY; Chen XW; Gong WQ; Chen WJ; Chen YH; Li PL; Li ST; Xu ZZ; Long HB
Cell Death Dis; 2016 Nov; 7(11):e2477. PubMed ID: 27882943
[TBL] [Abstract][Full Text] [Related]
9. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
Gao J; Liang Z; Zhao F; Liu X; Ma N
Bioengineered; 2022 May; 13(5):12275-12288. PubMed ID: 35603354
[TBL] [Abstract][Full Text] [Related]
10. Protective Effect of
Gong P; Yue S; Shi F; Yang W; Yao W; Chen F; Guo Y
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446560
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of lncRNA-PAX8-AS1-N directly associated with VEGF/TGF-β1/8-OhdG enhances podocyte apoptosis in diabetic nephropathy.
Shen Y; Tong ZW; Zhou Y; Sun Y; Xie Y; Li R; Liu H
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6864-6872. PubMed ID: 32633379
[TBL] [Abstract][Full Text] [Related]
12. LncRNA Hoxb3os protects podocytes from high glucose-induced cell injury through autophagy dependent on the Akt-mTOR signaling pathway.
Jin J; Gong J; Zhao L; Li Y; He Q
Acta Biochim Pol; 2021 Oct; 68(4):619-625. PubMed ID: 34648253
[TBL] [Abstract][Full Text] [Related]
13. p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway.
Zheng D; Tao M; Liang X; Li Y; Jin J; He Q
Histol Histopathol; 2020 Apr; 35(4):405-415. PubMed ID: 31650524
[TBL] [Abstract][Full Text] [Related]
14. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
15. Urinary exosomes from patients with diabetic kidney disease induced podocyte apoptosis via microRNA-145-5p/Srgap2 and the RhoA/ROCK pathway.
Han L; Wang S; Li J; Zhao L; Zhou H
Exp Mol Pathol; 2023 Dec; 134():104877. PubMed ID: 37952894
[TBL] [Abstract][Full Text] [Related]
16. Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activation.
Zhang Q; Hu Y; Hu JE; Zhang M
Drug Dev Res; 2022 Nov; 83(7):1697-1706. PubMed ID: 36048966
[TBL] [Abstract][Full Text] [Related]
17. ARHGEF7 (
Matsuda J; Maier M; Aoudjit L; Baldwin C; Takano T
J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698
[TBL] [Abstract][Full Text] [Related]
18. NMDA receptors participate in the progression of diabetic kidney disease by decreasing Cdc42-GTP activation in podocytes.
Shen J; Wang R; He Z; Huang H; He X; Zhou J; Yan Y; Shen S; Shao X; Shen X; Weng C; Lin W; Chen J
J Pathol; 2016 Oct; 240(2):149-60. PubMed ID: 27338016
[TBL] [Abstract][Full Text] [Related]
19. Dissection of Glomerular Transcriptional Profile in Patients With Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function.
Pan Y; Jiang S; Hou Q; Qiu D; Shi J; Wang L; Chen Z; Zhang M; Duan A; Qin W; Zen K; Liu Z
Diabetes; 2018 Apr; 67(4):717-730. PubMed ID: 29242313
[TBL] [Abstract][Full Text] [Related]
20. MiR-21-5p in macrophage-derived extracellular vesicles affects podocyte pyroptosis in diabetic nephropathy by regulating A20.
Ding X; Jing N; Shen A; Guo F; Song Y; Pan M; Ma X; Zhao L; Zhang H; Wu L; Qin G; Zhao Y
J Endocrinol Invest; 2021 Jun; 44(6):1175-1184. PubMed ID: 32930981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
